Cardiac rehabilitation in African Americans: Evidence for poorer outcomes compared with whites, especially in women and diabetic participants

American Heart Journal

Volumn 169, Issue 1, 2015, Pages 102-107

  Johnson, Dominic ^a   Sacrinty, Matthew ^a   Mehta, Hardik ^a   Douglas, Christopher ^a   Paladenech, Connie ^a   Robinson, Killian ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETIC PATIENT; ETHNIC GROUP; EXERCISE; FEMALE; HEART REHABILITATION; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SEX DIFFERENCE; AGED; BLOOD; COMPARATIVE STUDY; DIABETIC ANGIOPATHIES; EXERCISE TOLERANCE; OUTCOME ASSESSMENT; RISK FACTOR;

AFRICAN AMERICANS; AGED; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RISK FACTORS;

EID: 84925884690     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.09.009     Document Type: Article

References (35)

1. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116 (10):682-92.
2. Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011;7(CD001800):1-10.
3. Suaya JA, Shepard DS, Normand SL, et al. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 2007;116(15):1653-62.
4. Sanderson BK, Mirza S, Fry R, et al. Secondary prevention outcomes among black and white cardiac rehabilitation patients. Am Heart J 2007;153(6):980-6.
5. Allen JK, Scott LB, Stewart KJ, et al. Disparities in women's referral to and enrollment in outpatient cardiac rehabilitation. J Gen Intern Med 2004;19(7):747-53.
6. Cannistra LB, O'Malley CJ, Balady GJ. Comparison of outcome of cardiac rehabilitation in black women and white women. Am J Cardiol 1995;75(14):890-3.
7. Thompson WR, Gordon NF, Pescatello LS. ACSM's guidelines for exercise testing and prescription8th ed. . Philadelphia: Wolters Kluwer, Lippincott, Williams & Wilkins. 2010.
8. Whaley MH, Brubaker PH, Otto RM, et al. ACSM's guidelines for exercise testing and prescription. 7th ed. Philadelphia, PA: Lippincott, Williams & Wilkins. 2006.
9. Alderman MH. JNC 7: brief summary and critique. Clin Exp Hypertens 2004;26(7-8):753-61.
10. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
11. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2011;34(Supplement 1):S11-61.
12. Fishman AP, ed. Fishman's pulmonary diseases and disorders. 4th ed. New York: McGraw Hill Medical; 2008.
13. Otto CM, ed. Textbook of clinical echocardiography. 4th ed. Philadelphia, PA: Saunders/Elsevier; 2009.
14. Ferrans CE, Powers MJ. Quality of life index. Chicago, IL: College of Nursing, University of Illinois at Chicago. 1998-1984.
15. Lavie CJ, Kuruvanka T, Milani RV, et al. Exercise capacity in adult African-Americans referred for exercise stress testing: is fitness affected by race? Chest 2004;126(6):1962-8.
16. Turner BJ, Hollenbeak CS, WeinerM, et al. A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control. BMC Cardiovasc Disord 2011;11(58):1-10.
17. Fong RL, Ward HJ. The efficacy of lovastatin in lowering cholesterol in African Americans with primary hypercholesterolemia. Am J Med 1997;102(4):387-91.
18. Brown TM, Hernandez AF, Bittner V, et al. Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program. J Am Coll Cardiol 2009;54(6):515-21.
19. Scott LA, Ben-Or K, Allen JK. Why are women missing from outpatient cardiac rehabilitation programs? A review of multilevel factors affecting referral, enrollment, and completion. J Womens Health (Larchmt) 2002;11(9):773-91.
20. Valencia HE, Savage PD, Ades PA. Cardiac rehabilitation participation in underserved populations. Minorities, low socioeconomic, and rural residents. J Cardiopulm Rehabil Prev 2011;31(4):203-10.
21. Daniels KM, Arena R, Lavie CJ, et al. Cardiac rehabilitation for women across the lifespan. Am J Med 2012;125(9):937.e1-7.
22. Winston GJ, Barr RG, Carrasquillo O, et al. Sex and racial/ethnic differences in cardiovascular disease risk factor treatment and control among individuals with diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2009;32:1467-9.
23. Chatterji P, Joo H, Lahiri K. Racial/ethnic-and education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes. Diabetes Care 2012;35(2): 305-12.
24. Egede LE, Gebregziabher M, Lynch CP, et al. Longitudinal ethnic differences in multiple cardiovascular risk factor control in a cohort of US adults with diabetes. Diabetes Res Clin Pract 2011;94(3):385-94.
25. Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 2013;36(8):2271-9.
26. Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation 2005;111(10): 1233-41.
27. Nathan DM, Bayless M, Cleary P, et al. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes 2013;62(12):3976-86.
28. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351(9118): 1755-62.
29. Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376 (9753):1670-81.
30. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000;283(15):1967-75.
31. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360(9346):1623-30.
32. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. 1991;265:3255-6.
33. Shook RP, Hand GA, Wang X, et al. Low fitness partially explains resting metabolic rate differences between African American and white women. Am J Med 2014;127(5):436-42.
34. Swift DL, Johannsen NM, Lavie CJ, et al. Racial differences in the response of cardiorespiratory fitness to aerobic exercise training in Caucasian and African American postmenopausal women. J Appl Physiol 2013;114(10):1375-82.
35. Swift DL, Staiano AE, Johannsen NM, et al. Low cardiorespiratory fitness in African Americans: a health disparity risk factor? Sports Med 2013;43(12):1301-13.